Who owns Humacyte, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of HUMA from SEC Form 13F filings across 164 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 164 institutions disclosed 73.4M shares of Humacyte, Inc. worth $57.3M — about 31.3% of shares outstanding; the largest disclosed holder is VANGUARD CAPITAL MANAGEMENT LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
164
13F holders
$57.3M
value, 2026 filers
31.3%
of shares outstanding (73.4M sh)
42
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of HUMA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 10.1M | $7.9M | 0.0% | 4.3% | +41.2% |
| 2 | ANTIPODES PARTNERS Ltd | 10.1M | $7.9M | 0.1% | 4.3% | +76.5% |
| 3 | Alyeska Investment Group, L.P.NEW | 6.0M | $4.7M | 0.0% | 2.6% | new |
| 4 | Davidson Kempner Capital Management LPNEW | 5.0M | $3.9M | 0.0% | 2.1% | new |
| 5 | BlackRock, Inc. | 4.8M | $3.8M | 0.0% | 2.1% | -60.7% |
| 6 | GREAT POINT PARTNERS LLC | 3.8M | $2.9M | 0.6% | 1.6% | 0.0% |
| 7 | UBS Group AG | 2.8M | $2.2M | 0.0% | 1.2% | +2.2% |
| 8 | AQR CAPITAL MANAGEMENT LLC | 2.6M | $2.0M | 0.0% | 1.1% | +34.9% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.2M | $1.7M | 0.0% | 0.9% | -40.3% |
| 10 | MILLENNIUM MANAGEMENT LLC | 1.9M | $1.5M | 0.0% | 0.8% | +1665.1% |
| 11 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.7M | $1.3M | 0.0% | 0.7% | +60.6% |
| 12 | CITADEL ADVISORS LLCNEW | 1.4M | $1.1M | 0.0% | 0.6% | new |
| 13 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.4M | $1.1M | 0.0% | 0.6% | +4.8% |
| 14 | VANGUARD FIDUCIARY TRUST CO | 1.2M | $921,395 | 0.0% | 0.5% | +16.8% |
| 15 | HRT FINANCIAL LPNEW | 1.1M | $850,000 | 0.0% | 0.5% | new |
| 16 | LPL Financial LLC | 1.0M | $800,327 | 0.0% | 0.4% | +18.6% |
| 17 | GSA CAPITAL PARTNERS LLP | 1.0M | $785,000 | 0.0% | 0.4% | +302.5% |
| 18 | Private Advisor Group, LLC | 965,091 | $753,156 | 0.0% | 0.4% | +15.9% |
| 19 | STATE STREET CORP | 842,537 | $657,516 | 0.0% | 0.4% | -72.3% |
| 20 | HBK INVESTMENTS L PNEW | 790,000 | $616,516 | 0.0% | 0.3% | new |
| 21 | WEALTH EFFECTS LLC | 693,920 | $541,535 | 0.1% | 0.3% | +239.3% |
| 22 | LuminArx Capital Management LPNEW | 650,000 | $507,260 | 0.2% | 0.3% | new |
| 23 | Lion Point Capital, LP | 650,000 | $507,260 | 2.4% | 0.3% | 0.0% |
| 24 | GOLDMAN SACHS GROUP INC | 586,524 | $457,723 | 0.0% | 0.3% | -13.4% |
| 25 | BANK OF AMERICA CORP /DE/ | 578,592 | $451,303 | 0.0% | 0.2% | +46.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.